Avid Bioservices Inc (CDMO)

[skweze]

entdoc,

Agree the company has come a long way since TCLN. I think we're still two years away from "big" status, but I can see being somewhere in the $8-16 range by end of year. Still, biotech stocks are a wild ride, and a HUGE run (and retrace) between now and the end of PH III would not be a surprise at all.

skweze,one last thing before you hit the vin et cuisine: You said, "Those interested in "clinical stage biotechs" are probably already in". Methinks there is an enormously improved outlook for PPHM now vs. when I bought into PPHM Cotara story 15 years ago. PPHM is IMO a very advanced-stage biotech soon to become a mid-size big pharma...or the partner of one. I agree that the company still must turn the playbook to that page.